Transcutaneous Tibial Nerve Stimulation In The Treatment Of Lower Urinary Tract Symptoms And Its Impact On Health-related Quality Of Life In Patients With Parkinson Disease A Randomized Controlled Trial

dc.creatorPerissinotto
dc.creatorMaria Carolina; Levi D'Ancona
dc.creatorCarlos Arturo; Lucio
dc.creatorAdelia; Campos
dc.creatorRenata Martins; Abreu
dc.creatorAnelyssa
dc.date2015-JAN-FEB
dc.date2016-06-07T13:14:59Z
dc.date2016-06-07T13:14:59Z
dc.date.accessioned2018-03-29T01:35:43Z
dc.date.available2018-03-29T01:35:43Z
dc.identifier
dc.identifierTranscutaneous Tibial Nerve Stimulation In The Treatment Of Lower Urinary Tract Symptoms And Its Impact On Health-related Quality Of Life In Patients With Parkinson Disease A Randomized Controlled Trial. Lippincott Williams & Wilkins, v. 42, p. 94-99 JAN-FEB-2015.
dc.identifier1071-5754
dc.identifierWOS:000347460800015
dc.identifier10.1097/WON.0000000000000078
dc.identifierhttp://www.ncbi.nlm.nih.gov/pubmed/25549314
dc.identifierhttp://repositorio.unicamp.br/jspui/handle/REPOSIP/241762
dc.identifier.urihttp://repositorioslatinoamericanos.uchile.cl/handle/2250/1305460
dc.descriptionPURPOSE: A randomized controlled trial study was performed to evaluate the efficacy of transcutaneous tibial nerve stimulation (TTNS) and sham TTNS, in patients with Parkinson disease (PD) with lower urinary tract symptoms (LUTS). DESIGN: Randomized controlled trial. SUBJECTS AND SETTINGS: Thirteen patients with a diagnosis of PD and bothersome LUTS were randomly allocated to one of the following groups: Group I: TTNS group (n = 8) and group II: Sham group (n = 5). Both groups attended twice a week during 5 weeks; each session lasted 30 minutes. METHODS: Eight patients received TTNS treatment and 5 subjects allocated to group II were managed with sham surface electrodes that delivered no electrical stimulation. Assessments were performed before and after the treatment; they included a 3-day bladder diary, Overactive Bladder Questionnaire (OAB-V8), and the International Consultation on Incontinence Quality of Life Questionnaire Short Form (ICIQ-SF), and urodynamic evaluation. RESULTS: Following 5 weeks of treatment, patients allocated to TTNS demonstrated statistically significant reductions in the number of urgency episodes (P = .004) and reductions in nocturia episodes (P < .01). Participants allocated to active treatment also showed better results after treatment in the OAB-V8 and ICIQ-SF scores (P < .01, respectively). Urodynamic testing revealed that patients in the active treatment group showed improvements in intravesical volume at strong desire to void (P < .05) and volume at urgency (P < .01) when compared to subjects in the sham treatment group. CONCLUSION: These findings suggest that TTNS is effective in the treatment of LUTS in patients with PD, reducing urgency and nocturia episodes and improving urodynamic parameters as well as symptom scores measured by the OAB-V8 and health-related quality-of-life scores measured by the ICIQ-SF.
dc.description42
dc.description1
dc.description
dc.description94
dc.description99
dc.description
dc.description
dc.description
dc.languageen
dc.publisherLIPPINCOTT WILLIAMS & WILKINS
dc.publisher
dc.publisherPHILADELPHIA
dc.relationJOURNAL OF WOUND OSTOMY AND CONTINENCE NURSING
dc.rightsfechado
dc.sourceWOS
dc.subjectNeurogenic Detrusor Overactivity
dc.subjectMultiple-sclerosis
dc.subjectElectrical-stimulation
dc.subjectVoiding Dysfunction
dc.subjectBladder
dc.subjectIncontinence
dc.subjectTherapy
dc.subjectSociety
dc.subjectWomen
dc.titleTranscutaneous Tibial Nerve Stimulation In The Treatment Of Lower Urinary Tract Symptoms And Its Impact On Health-related Quality Of Life In Patients With Parkinson Disease A Randomized Controlled Trial
dc.typeArtículos de revistas


Este ítem pertenece a la siguiente institución